Gu Shenghan
Executive Director @ Sunland Fund
Shanghai, China
Gu Shenghan is a seed investor at Sunland Fund in Shanghai focused on Health Care and Medical Device. Gu Shenghan works as an executive director of Sunland Fund.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Gu Shenghan invests in
Stages Gu Shenghan invests in
Countries Gu Shenghan invests in
Investment Focus
Industry
- Health Care 4 (67%)
- Medical Device 4 (67%)
- Medical 3 (50%)
- Sales 1 (17%)
- Women's 1 (17%)
Stage
- Seed 2 (33%)
- Series A 2 (33%)
- Series B 2 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Insight Technology
|
Insight Technology is an instrument manufacturer and seller company that specializes in instrument sales, intelligent instrument sales, mechanical equipment research and development, and more. | Seed / Jul 07, 2026 | |
Medtech Technology
|
Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture. | $28.2M / Series B / Sep 14, 2024 | |
Better Medtech
|
Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies. | $14.1M / Seed / Jan 12, 2024 | |
|
Juhe Biotechnology
|
Juhe Biotechnology is a company that creates early detection tools for gynecological malignancies. | $14M / Series B / Dec 27, 2023 | |
Jiyuan Medical
|
Jiyuan Medical focuses on disposable gynecological endoscopes and peripheral products. Its products include disposable electronic hysteroscopes (including 4K high-definition mirrors, resectoscopes, fluoroscopes, near-infrared mirrors, and NBI mirrors), disposable gynecological minimally invasive surgical instruments, hysteroscopes Intelligentworkstations, disposable fetoscopes, and disposable mammoscopes to create an overall solution for disposable gynecological endoscopes based on disposable electronic hysteroscopes. | Series A / Jul 19, 2023 | |
NeuroEchos
|
Nuoer Medical was established in August 2017, focusing on the field of functional neurosurgery, with precise EEG as the entry point, providing integrated diagnosis and treatment solutions for various diseases caused by abnormal discharge of the nervous system. | $15.8M / Series A / Feb 28, 2022 |
Co-Investors
About Sunland Fund
Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..
Sunland Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Daozhi Liu
Founder
|
|||
|
Gu Shenghan
Executive Director
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Gu Shenghan invest in?
Gu Shenghan invests primarily in Health Care, Medical Device and Medical startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Gu Shenghan last invest?
The most recent investment recorded for Gu Shenghan closed in Jul 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
